Patent · US Active

Compounds useful for treating disorders related to RET

US10227329B2 · kind B2 · utility

16Cited by
20References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 21, 2017
Grant dateMar 12, 2019
Priority date
Expiry dateJul 21, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Described herein are compounds that inhibit wild-type RET and its resistant mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.